RPG Life SciencesNSE:RPGLIFE -0.54%93 Operating Margin % is 15.31% as of Mar. 2026, which is 0% below its 10-year median of 15.34. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 93/100 and a GF Value™ of ₹2,359.10 (Fairly Valued). The stock has 3 warning signs investors should review. Among 955 Drug Manufacturers companies, RPG Life Sciences ranks better than 77.28% on this metric.
RPG Life Sciences Ltd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for RPG Life Sciences's Operating Margin % or its related term are showing as below:
NSE:RPGLIFE'
s Operating Margin % Range Over the Past 10 Years
Min: 5.92 Med: 15.34 Max: 21.15
Current: 17.75
NSE:RPGLIFE's Operating Margin % is ranked better than 77.28% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs NSE:RPGLIFE: 17.75
RPG Life Sciences's 5-Year Average Operating Margin % Growth Rate was 5.80% per year.
RPG Life Sciences (NSE:RPGLIFE) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
RPG Life Sciences Operating Margin % Related Terms
RPG Life Sciences Operating Margin % Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Operating Margin % distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
RPG Life Sciences's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RPG Life Sciences (NSE:RPGLIFE) has a Operating Margin % of 15.31% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on RPG Life Sciences and its competitors. This is near median its historical median of 15.34. Over the past decade, RPG Life Sciences' Operating Margin % has ranged from 5.92 to 21.15. According to the industry distribution chart, RPG Life Sciences ranks #217 out of 955 companies in the Drug Manufacturers industry, placing it in the top 22.7%.
Is RPG Life Sciences' Operating Margin % too high?
RPG Life Sciences' current Operating Margin % of 15.31% is near median its 10-year median of 15.34. Over the past 10 years, this metric has ranged from a low of 5.92 to a high of 21.15. The Drug Manufacturers industry median Operating Margin % is 7.45. RPG Life Sciences' value of 15.31% is 105.5% above this industry median. Based on the distribution chart, RPG Life Sciences ranks #217 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, RPG Life Sciences has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #217 out of 955 companies for Operating Margin %. This places RPG Life Sciences in the top 23% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.45. RPG Life Sciences' value of 15.31% is 105.5% above this benchmark. Historically, RPG Life Sciences' own Operating Margin % has ranged from 5.92 to 21.15 over the past decade. While the company's 10-year median is 15.34 vs. the industry median of 7.45, RPG Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RPG Life Sciences's current Operating Margin % of 15.31% is 105.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Operating Margin % is 15.31%, which is near median its own 10-year median of 15.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,359.10, compared to a current price of ₹2,276.40 — trading 3.5% below its estimated fair value. The current Operating Margin % is 15.31%, which is near median its 10-year median of 15.34 and 105.5% above the Drug Manufacturers industry median of 7.45. RPG Life Sciences' overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Operating Margin % is 15.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be undervalued.
The current stock price of ₹2,276.40 is trading 3.5% below its estimated GF Value™ of ₹2,359.10.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Operating Margin %: 15.31% (near median its 10-year median of 15.34)
GF Value™: ₹2,359.10 vs. price of ₹2,276.40 (3.5% below fair value)
Industry Position: 105.5% above the Drug Manufacturers median (#217 of 955)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
93GF Score
Get the complete analysis for NSE:RPGLIFE
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
